NL-OMON26747尚未招募不适用
Validation of Treating to Non-Fasting Lipid Targets in Comparison to Fasting Lipid Targets
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 350
研究概览
简要总结
- Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., and Ridker, P. M. (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA.298, 309-316
3. Eberly, L. E., Stamler, J., and Neaton, J. D. (2003) Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch Intern Med.163, 1077-1083
4. Mora, S., Rifai, N., Buring, J. E., and Ridker, P. M. (2008) Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation.118, 993-1001
5. Nordestgaard, B. G., Benn, M., Schnohr, P., and Tybjaerg-Hansen, A. (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA.298, 299-308
6. Langsted, A., and Nordestgaard, B. G. (2011) Nonfasting Lipids, Lipoproteins, and Apolipoproteins in Individuals with and without Diabetes: 58 434 Individuals from the Copenhagen General Population Study. Clin Chem.57, 482-489
7. Klop, B., Cohn, J. S., van Oostrom, A. J., van Wijk, J. P., Birnie, E., and Castro Cabezas, M. (2011) Daytime triglyceride variability in men and women with different levels of triglyceridemia. Clin Chim Acta.412, 2183-2189
8. Sidhu, D., and Naugler, C. (2012) Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med.172, 1707-1710
9. de Vries, M., Klop, B., and Castro Cabezas, M. (2014) The use of the non-fasting lipid profile for lipid-lowering therapy in clinical practice - point of view. Atherosclerosis.234, 473-475
10. Khera, A. V., and Mora, S. (2012) Fasting for lipid testing: is it worth the trouble?: comment on "fasting time and lipid levels in a community-based population". Arch Intern Med.172, 1710-1711
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male and female patients, aged 18 years or older, from the outpatient department of Cardiology and Internal Medicine receiving lipid lowering therapy as secondary cardiovascular prevention are suitable for inclusion. Lipid lowering therapy is defined as the use of statins, fibrates, ezetimibe or nicotinic acid or a combination of these
排除标准
- •A change in lipid lowering therapy within the last 4 weeks is an exclusion criterium for study participation.
研究者
相似试验
已完成
不适用
Validation of Treating to Non-Fasting Lipid Targets in Comparison to Fasting Lipid Targetshypercholesterolemia1001108210013317HyperlipidemiaNL-OMON41824Albert Schweitzer Ziekenhuis352
尚未招募
不适用
Study on lipid profile in PCOS patientsCTRI/2021/06/034250KMC Manipal
已完成
不适用
Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes PatientsDiabetes MellitusNormal Glucose MetabolismHyperlipidemiaNCT00569959HealthPartners Institute50
招募中
不适用
Fasting and non-fasting lipid profile in patients with acute coronary syndromeLipid profileLDL-CFasting LDL-Non-fasting LDL-Acute Coronary SyndromeTCTR20200129001Faculty of Medicine, Chiang Mai University210
已完成
1 期
A Food Effect Study of SHR2554 on Healthy Chinese Male Adult SubjectsHealthy Adult SubjectsNCT04335266Jiangsu HengRui Medicine Co., Ltd.20